Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Sarcoma, Alveolar Soft Part 1Radiodermatitis 1Keratosis, Actinic 1Head and Neck Neoplasms 1Dermatitis 1Breast Neoplasms 1

Interventions

Cyclophosphamide 910Carboplatin 787pembrolizumab 746Paclitaxel 744Bevacizumab 716Cisplatin 708Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 338Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Petrolatum × Clear all
NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
34 enrolled 22 charts
Sarcoma

Sarcoma, Alveolar Soft Part

NCT04865731 2025-08-06

Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer

The University of Texas Health Science Center at San Antonio

Phase 2 Completed
6 enrolled 7 charts
Head & Neck

Head and Neck Neoplasms

NCT02534129 2017-10-06

Topical Use of Difinsa53â„¢ to Prevent Radiation Dermatitis

ProTechSure Scientific, Inc.

Phase 1/2 Terminated
13 enrolled 3 charts
Breast

Breast Neoplasms, Dermatitis, Radiodermatitis

NCT00786994 2015-09-14

The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses

Amryt Pharma

Phase 2 Completed
165 enrolled 10 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡